360 Grand Est 2021



Transgene S.A

Directeur scientifique


Eric Quéméneur is an engineer, pharmacist and doctor of science, holding an HDR. He is the Chief Scientific Officer of Transgene, a company he joined at the end of 2014 with the mission of renewing its portfolio of oncology technologies and products. Four products, two anti-tumor vaccines and two oncolytic viruses are in clinical development and the two platforms myvac and invirio are the subject of partnerships with pharmas. His career has always been marked by innovation and multidisciplinarity, at the interface between biology and physical sciences, convinced of the fluid continuum between research and industrial applications. He also contributes to the national reflection on artificial intelligence applied to the fight against cancer and sits on the board of several biotechnology companies.

This speaker will talk about

Find here the list of all the sessions presented by this speaker in order not to miss any of it.